Cell and gene therapies use the body's building blocks - cells and genetic material - to boost the immune system or correct ...

Zanidatamab shows promise in extending survival for patients with HER2-positive biliary tract cancer, marking a significant ...

Bimekizumab exhibited superior drug survival rates among patients with psoriasis who have previously stopped responding to at ...

Atacicept, a novel dual inhibitor of BAFF and APRIL, receives FDA Priority Review for IgA nephropathy treatment in adults.

With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...